← Back to Clinical Trials
Recruiting NCT07070336

NCT07070336 Neuroathletic Exercise In The Elderly

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07070336
Status Recruiting
Phase
Sponsor KTO Karatay University
Condition Healthy Aging
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-05-01
Primary Completion 2026-10-01

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Neuroathletic exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-05-01 with a primary completion date of 2026-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Objective: The aim of this protocol study was to investigate the effect of neuroathletic exercise on walking speed, fall risk and cognitive function in the elderly. Method: The study is planned as a single-centre, double-blind, parallel group randomised controlled experimental design and will be conducted in accordance with SPIRIT. The sample of the study will consist of healthy elderly people aged 60-80 years. In order to ensure parametric conditions, the sample will be divided into two groups as experimental group (n=20) in which neuroathletic exercise will be performed and control group (n=20) in which Turkey Physical Activity Guidelines will be given and a total of 40 elderly people will be randomly assigned to the groups. The elderly assigned to the experimental and control groups according to the order of randomisation will be administered the timed up and go test (TUG), short physical performance battery (SPPB), geriatric depression scale (GDÖ), MoCA test as pre-test and post-test. The experimental group will be asked to perform neuroathletic exercises two days a week for 12 weeks under the supervision of a physiotherapist, and will be asked to perform a home exercise programme one day a week. The control group will be given the Turkish Physical Activity guide. Data will be collected by the researcher. Results: Considering the limited number of studies on the use of neuroathletic exercises in the literature, it is thought that our randomised controlled study designed to determine the effect of neuroathletic exercise on walking speed, fall risk and cognitive functions in the elderly will contribute to the literature.

Eligibility Criteria

Inclusion Criteria: * Ages between 60-80 * Volunteering to participate in the study * Having the ability to perform physical, cognitive and sensory tests and exercises Exclusion Criteria: * Having a history of injury to the lower and upper extremities within the last year * Having regular physical activity or sports habits. * Having participated in any physical activity program in the last 6 months * Having a sensory pathology that prevents participation in the study * Having any musculoskeletal, neurological, respiratory or cardiovascular pathology that will limit exercise * Having a history of malignant disease * Having an eye defect that cannot be corrected with lenses, such as cataracts, that prevents tests

Contact & Investigator

Central Contact

Merve arı

✉ merveari89@gmail.com

📞 05458898689

Frequently Asked Questions

Who can join the NCT07070336 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, up to 80 Years, studying Healthy Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07070336 currently recruiting?

Yes, NCT07070336 is actively recruiting participants. Contact the research team at merveari89@gmail.com for enrollment information.

Where is the NCT07070336 trial being conducted?

This trial is being conducted at Konya, Turkey (Türkiye).

Who is sponsoring the NCT07070336 clinical trial?

NCT07070336 is sponsored by KTO Karatay University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology